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Abstract
Background: Dynamin-related protein 1 (Drp1) is a mitochondrial fission protein that, upon phosphorylation at
serine 616 (p-Drp1(Ser616)), plays a pivotal role in neuronal death after ischemia. In the present study, we hypothesized
that peroxisome proliferator-activated receptor-gamma (PPARγ)-dependent pathway can reduce the expression of
p-Drp1(Ser616) and ameliorate hippocampal injury induced by global ischemia in rats.
Results: We found that pretreatment of the rats with Mdivi-1, a selective Drp1 inhibitor, decreased the level of
transient global ischemia (TGI)-induced p-Drp1(Ser616) and reduced cellular contents of oxidized proteins, activated
caspase-3 expression as well as the extent of DNA fragmentation. Delivery of siRNA against Drp1 attenuated the
expression of p-Drp1(Ser616) that was accompanied by alleviation of the TGI-induced protein oxidation, activated
caspase-3 expression and DNA fragmentation in hippocampal proteins. Exogenous application of pioglitazone, a PPARγ
agonist, reduced the p-Drp1(Ser616) expression, decreased TGI-induced oxidative stress and activated caspase-3
expression, lessened the extents of DNA fragmentation, and diminished the numbers of TUNEL-positive neuronal cells;
all of these effects were reversed by GW9662, a PPARγ antagonist.
Conclusions: Our findings thus indicated that inhibition of TGI-induced p-Drp1(Ser616) expression by Drp1 inhibitor
and Drp1-siRNA can decrease protein oxidation, activated caspase-3 expression and neuronal damage in the
hippocampal CA1 subfield. PPARγ agonist, through PPARγ-dependent mechanism and via decreasing p-Drp1(Ser616)
expression, can exert anti-oxidative and anti-apoptotic effects against ischemic neuronal injury.
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Background
Mitochondria are the powerhouses of cells to produce
ATP as well as to regulate signaling cascades, including
apoptosis [1]. A recent progress towards the understand-
ing of mitochondrial control over apoptosis is the
discovery of a drastic morphological change of this or-
ganelle under stressful conditions [2, 3]. Mitochondria
are dynamic organelles that maintain their shape or
morphology via two opposing processes: fission and fu-
sion [4–6]. While the fission process involves the con-
striction and cleavage of mitochondria, fusion process
involves the lengthening of mitochondria by tethering
and joining two adjacent mitochondria together [4–6]. It
was shown that, just before the apoptotic processes,
mitochondria fragment into multiple small units (fission)
and blocking mitochondrial fission can inhibit cyto-
chrome c release with delayed cell death [2]. Drp1, an
important fission protein, plays a crucial role in focal
cerebral ischemia and inhibition of Drp1 can reduce the
infarct volumes [7–9]. Expression of the dominant-
negative Drp1 mutant in cell lines decreases mitochon-
drial fragmentation and blocks cell death in response to
various apoptotic insults [10, 11].
A selective neuronal loss in hippocampal CA1 subfield
is a histological hallmark of transient global ischemia
(TGI) and reperfusion [12, 13]. This condition occurs in
patients with anoxic-ischemic encephalopathy and car-
diorespiratory arrest of various causes [14] The damage
may cause long-term cognitive change as the hippocam-
pus is an important player in memory consolidation and
in conjunction with other cortical areas, is critical for
the retrieval of remote episodic memories and antero-
grade memory processes [15]. Emerging evidence sug-
gests that the mitochondrion may play a major role in
delayed neuronal death of the CA1 subfield after TGI
[16–19]. Recent evidence implicates the regulatory pro-
cesses of mitochondrial biogenesis as a protective effect
in the pathogenesis of cerebral ischemia [18, 20]. Lately,
mitochondrial dynamic has been recognized as a pivotal
process in regulating cell survival and death; in particu-
lar, mitochondrial fission occurs as an upstream and
early event in neuronal death after cerebral ischemia
[7–9]. Recently, we have also shown that TGI induced
a transient increase in the phosphorylation of Drp1 at
serine 616 (p-Drp1(Ser616)), without significantly af-
fecting the expression of total Drp1 proteins or its
phosphorylation at serine 637, in the rat hippocampal
CA1 proteins [21]. Together these findings support
the crucial roles of mitochondrial dynamics in ische-
mic neuronal death.
Peroxisome proliferator-activated receptor gamma
(PPARγ) agonist, such as pioglitazone or rosiglitazone
has been shown to reduce inflammation [22, 23], de-
crease oxidative damage [23–27], and reduce cell death
following ischemic injury. Despite its ability of enhan-
cing mitochondrial biogenesis [28], however, the potential
correlation between PPARγ agonist and mitochondrial
dynamics, in particular its effects on the expression
of p-Drp1(Ser616), has never been investigated before.
To resolve this question, we hypothesized that PPARγ-
dependent mechanism may exert anti-oxidative and anti-
apoptotic effects against TGI in rats which involves
p-Drp1(Ser616) expression. Results derived from this
work may further improve our understandings to-
wards the molecular mechanisms underlying TGI-
induced neuronal demise in the hippocampal CA1
subfield and provide novel insights for future develop-
ment of therapeutic regimen.
Methods
Animals and general preparations
All the animal studies followed the Guide for the Care
and Use of Laboratory Animals, National Research
Council, USA and were approved by the Institutional
Animal Care and Use Committee (IACUC) of Chang
Gung Memorial Hospital (Permit Number: 2009121704).
All efforts were made to minimize animal suffering and
to reduce the number of animals sacrificed. Adult male
Sprague-Dawley rats (250–325 g) were purchased from
BioLASCO, Taiwan. They were housed in an Association
for Assessment and Accreditation of Laboratory Animal
Care (AAALAC), an internationally accredited animal
facility, under temperature control (24–25 °C) and 12-h
light-dark cycle. Standard laboratory rat chow and tap
water were available ad libitum. Animals were anesthe-
tized with chloral hydrate (400 mg/kg, i.p.) to perform
preparative surgery. An experimental model of TGI was
performed as previously reported [29] with modifica-
tions [19, 21]. Briefly, the animals were subjected to a
10-min period of global ischemia by clamping both com-
mon carotid arteries and lowering blood pressure to 35–
40 mm-Hg by withdrawing blood from a femoral arterial
catheter; blood pressure was restored by infusing the
withdrawn blood afterwards. A PE-50 catheter was
inserted to femoral artery to continuously record the
arterial blood pressure and to keep blood pressure
within 35–40 mm-Hg. After regaining consciousness,
the animals were maintained in an air-conditioned room
at 25 °C.
Pharmacological pretreatments
In the experiments involving pharmacological pretreat-
ments, the dosage for Mdivi-1 was tested as previously
reported [8, 30], the dosage of GW9662 and pioglitazone
were based on our previous studies [26, 31]. One group
of rats were treated intraperitoneally with Drp1 inhibitor
Mdivi-1 (2.4 mg/kg), which was purchased from Sigma-
Aldrich Ltd (St. Louis, MO, USA), or the solvent
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dimethyl sulfoxide (DMSO) 30 min before TGI. The
other group of rats were microinjected into bilateral
CA1 subfields with pioglitazone (Cayman Chemical,
Ann Arbor, MI, USA; 20 nmol), GW9662 (Cayman
Chemical, 500 ng) or DMSO as the vehicle and volume
control 30 min before TGI. The test agents were micro-
injected bilaterally in a volume of 100 nl on each side.
Drug delivery into the hippocampal CA1 subfield was
carried out as previously reported [18, 19]. The animals
receiving chloral hydrate anesthesia and surgical prepa-
rations without additional experimental manipulations
served as sham-controls.
siRNA administration
All siRNAs were injected into bilateral hippocampal
CA1 subfield as previously described [19, 21, 32]. To
evaluate transfection efficiency, we used fluorescein iso-
thiocyanate (FITC)-conjugated siRNA as a non-targeting
siRNA (sc-36869; Santa Cruz Biotechnology, Santa Cruz,
CA, USA). As previously reported, animals were killed
24 h after administration of FITC-siRNA in sham-
control and 4 h after TGI/reperfusion before observation
under a fluorescence microscope [21]. To inhibit Drp1
expression, we used pre-designed Drp1-siRNA from
MISSION® siRNA, (Sigma-Aldrich Ltd.). The sequences
were as follows: sense, 5′CAGAGUAUUGUAACACU
AU3′, antisense, 5′AUAGUGUUACAAUACUCUG3′.
For negative control siRNA (NC), the sequences were as
follows: 5′GAUCAUACGUGCGAUCAGA3′, antisense,
5′UCUGAUCGCACGUAUGAUC3′. The final concen-
tration of siRNA was 0.05 nM in a total volume of
400 nl for injection into each side of hippocampal CA1
subfield 24 h before TGI.
Collection of tissue samples from the hippocampus
At predetermined time intervals (1, 4, 24, or 48 h)
after induction of TGI, rats were anesthetized and
perfused intracardially with 50 ml of warm (37 °C) sa-
line that contained heparin (100 U/ml). The tissues
from bilateral hippocampal CA1 area were collected
and concentration of proteins determined as previ-
ously reported [19, 21].
Detection of protein oxidation
The extent of protein oxidation was determined by a
commercial kit (OxyBlot, Chemicon, Temecula, CA).
Total proteins extracted from the hippocampal CA1
subfield at 24 h after ischemia/reperfusion were subjected
to reactions with 2,4-initrophenylhydrazine and deriva-
tized to 2,4-dinitrophenylhydrazone (DNP-hydrazone).
Western blotting using a rabbit anti-DNP antibody and
then incubated with horseradish peroxidase-conjugated
goat anti-rabbit secondary IgG antibody was performed
according to manufacturer’s instruction.
Western blot analysis
Western blot analysis for Drp1 and α-tublin was car-
ried out on proteins extracted from total lysates of
hippocampal samples. The primary antibody were
Drp1, p-Drp1(Ser616) and active cleaved fragment (17
and 19 kDa) of caspase-3 (Cell Signaling, Danvers, MA,
USA), or mouse monoclonal antiserum against α-tubulin
(Santa Cruz Biotechnology). The secondary antibody in-
cluded a horseradish peroxidase-conjugated goat anti-
rabbit (Chemicon) for Drp1 and p-Drp1(Ser616), donkey
anti-rabbit IgG (Amersham Biosciences, Little Chalfont,
U.K.) for activated caspase-3 and goat anti-mouse IgG
(Chemicon) for α-tubulin. The specific antibody-antigen
complex was detected and measured semiquantitatively as
previously reported [19, 21, 32].
Immunofluorescence staining
Immunofluorescence staining was carried out in animals
as reported previously [19]. Briefly, free-floating sections
(thickness = 30 μm) of the hippocampus were incubated
with a rabbit polyclonal antiserum against p-Drp1
(Ser616) (Cell Signaling) and a mouse monoclonal anti-
serum, neuron-specific nuclear protein (NeuN, Chemicon).
Two secondary antibodies were used that included a goat
anti-rabbit IgG-conjugated with Alexa Fluor 488 for
p-Drp1(Ser616) and a goat anti-mouse IgG conjugated
with Alexa Fluor 568 for NeuN (Molecular Probes,
Eugene, OR, USA). The merged images indicated the pres-
ence of p-Drp1(Ser616) immunoreactivity in the cytosol
and NeuN in the nucleus of neurons. For double immuno-
fluorescence staining of p-Drp1(Ser616) and COXIV, the
sections of the hippocampus were first incubated with a
rabbit polyclonal antiserum against p-Drp1(Ser616) (Cell
Signaling). The sections were subsequently incubated with
a goat anti-rabbit IgG conjugated with Alexa Fluor 488 for
p-Drp1(Ser616). After fixed with 4 % paraformaldehyde for
5 min, the same sections were incubated with a polyclonal
rabbit antiserum against COXIV (Cell Signaling) and then
with DyLight 405-conjugated AffiniPure goat anti-rabbit
IgG (Jackson ImmunoResearch, West Grove, PA, USA) for
labeling COX IV.
Qualitative and quantitative analysis of DNA fragmentation
Preparations of tissue samples from the hippocampal
CA1 subfield for qualitative and quantitative analysis of
DNA fragmentation was conducted as reported previously
[18, 19]. With total DNA from the hippocampal tissues,
nucleosomal DNA ladders were amplified using a DNA
ladder assay kit (Maxim Biotech, San Francisco, CA, USA)
as previously reported [19, 21]. Samples were sepa-
rated by electrophoresis on 1 % agarose gels. A cell death
enzyme-linked immunosorbent assay (Roche Molecular
Biochemicals, Mannheim, Germany) was used to assess
the level of histone-associated DNA fragments in the
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cytoplasm. The amount of nucleosomes in the cytoplasm
was determined using 2,20-azino-di-[3-ethylbenzthiazoline]
sulfonate as the substrate and the absorbance was mea-
sured as previously reported [19, 21].
Terminal deoxynucleotidyl transferase-mediated
dUTP-biotin nick end labeling (TUNEL) staining
Animals were processed for TUNEL staining 48 h after the
onset of reperfusion following a 10-min episode of TGI as
previously reported [21]. In brief, the hippocampus was
removed and fixed in 30 % sucrose in 10 % formaldehyde-
saline solution for ≥72 h. Six-micrometer paraffin-
embedded sections (thickness = 25 μm) of the hippocam-
pus were processed for TUNEL staining with an apoptosis
detection kit (ApopTag, Intergen Company, Purchase, NY,
USA). The total numbers of TUNEL-positive cells in each
section were counted using an Olympus AX70 microscope
and expressed as the TUNEL indices [21].
Statistical analysis
All values expressed as mean ± SEM. The one-way ana-
lysis of variance (ANOVA) was used, as appropriate, to
assess group means, followed by the Scheffe’ multiple-
range test for post-hoc assessment of individual mean.
P < 0.05 indicates statistical significance.
Results
Tem7poral changes of drp1 expressions in the
hippocampal CA1 subfield after TGI
We first examined whether Drp1 is induced by TGI in
the hippocampal CA1 subfield. The division of the mito-
chondria, which is required for apoptosis as well as nor-
mal cell growth and development, is controlled in part by
the phosphorylation of Drp1 at Ser616 by Cdk1/cyclin B
[33, 34]. We used Drp1 and phosphorylation of Drp1 at
Ser616 (p-Drp1(Ser616)) antibodies to examine the ex-
pression in the hippocampal CA1 subfield after TGI at the
designed time. Total Drp1 (Fig. 1a) revealed no significant
change and p-Drp1(Ser616) significantly increased as early
as 1 h after TGI and remained elevated until 24 and 48 h
after TGI in the total protein extracted from the hippo-
campal CA1 subfield (Fig. 1b, c). This finding may suggest
the active form, phosphorylated Drp-1(Ser616), in stead of
total Drp1 expression, plays the functional role on the fis-
sion process of mitochondria in this ischemic condition.
This notion was reported before that Drp1 phosphoryl-
ation at serine 616 results in its activation and recruitment
to mitochondria [35].
Effect of Drp1 inhibitor over p-Drp1(Ser616) expression,
oxidative stress and neuronal injury in the hippocampal
CA1 subfield After TGI
Mitochondrial biogenesis may function as an endogen-
ous protective mechanism [19, 20] while mitochondrial
Fig. 1 Transient induction of p-Drp1(Ser616) by TGI. Hippocampal CA1
samples were collected from the rats at indicated times after 10-min
TGI or sham-operated controls followed by protein extraction and
western analysis for detection of total Drp1 in (a) and p-Drp1(Ser616)
in (b). The same blots were also probed with α-tubulin antibody to
serve as an internal reference control for equal loading of proteins in
each lane. The ratio change of p-Drp1(Ser616)/total Drp was shown in
(c). Values are mean ± SEM from representative blots and quantitative
analyses from 4-6 animals in each experimental group are shown.
*P < 0.05 versus sham control group in the Scheff′e multiple-range test
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fission may initiate the apoptotic process under ischemic
insult [7, 8]. As Drp1 phosphorylation at Ser616 in rat
hippocampal CA1 regions shows a significant change
that peaked at 24 h after TGI, with no significant change
in total Drp1 protein expression after 1–48 h of reperfu-
sion, we then test if downregulation of p-Drp1(Ser616)
Fig. 2 Mdivi-1 reduced Drp1 phosphorylation, protein oxidation, and DNA fragmentation after TGI. Rats were treated intraperitoneally with Drp1
inhibitor Mdivi-1 (2.4 mg/kg) or its solvent DMSO 30 min before TGI. Total proteins were extracted from the hippocampal CA1 subfield of sham-
operated controls or treated animals 24 h after 10-min TGI for detection of p-Drp1(Ser616) in (a), protein oxidation in (b) and activated caspase-3
expression in (c). DNA was isolated from the hippocampal CA1 subfield of sham-operated controls, DMSO + I/R and Mdivi-1 + I/R 48 h after TGI
for detection of DNA fragmentation by PCR assay (d), protein lysates from hippocampal CA1 tissues were collected 48 h after TGI for detection of
DNA fragmentation by sandwich ELISA in (e). Values are mean ± SEM from representative blots and quantitative analysis from 5–6 animals
in each experimental group (a, b and c). Values in (e) are fold changes with reference to sham-operated controls and are mean ± SEM of
4 animals in each experimental group. *P < 0.05 versus sham control group, #P < 0.05 versus DMSO + I/R group in the Scheffé multiple-range test.
I/R: ischemia/reperfusion
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expression will exert beneficial effect over hippocampal
CA1 subfield under TGI. Firstly, we tested the effects of
Mdivi-1, a selective inhibitor of Drp1, over TGI-induced
p-Drp1(Ser616) expression. Western blot analysis re-
vealed a reduction of p-Drp1(Ser616) protein level in the
hippocampal CA1 subfield 24 h after TGI in the Mdivi-
1-treated group as compared to the vehicle groups
(Fig. 1a). An excessive production of ROS underlies
neuronal cell death in the CA1 subfield of the hippo-
campus after TGI [18, 19]. We therefore investigated the
effects of Mdivi-1, which is capable of reducing TGI-
induced phosphorylation of Drp1 at Ser616 (Fig. 2a),
over ischemia-dependent oxidative stress and apoptosis
related molecule. We found that, at 24 h following TGI,
protein oxidation as well as activated caspase-3 expression
in the hippocampal CA1 subfield decreased significantly
by pretreatment with Mdivi-1 (Fig. 2b, c). We have also
shown that an excessive production of ROS underlies
DNA fragmentation and neuronal damage in the hippo-
campal CA1 subfield after TGI [18, 19]. Our results de-
rived from both qualitative (Fig. 2d) and quantitative
(Fig. 2e) analyses of DNA fragmentation indicated that, at
48 h following TGI, apoptosis-like cell death decreased
significantly by pretreatment of Mdivi-1. Thus, Mdivi-1
capable of reducing the extent of phosphorylation Drp1 at
Ser616 also attenuates the TGI-mediated oxidative dam-
age and neuronal injury in rat hippocampal CA1 regions.
Drp1-siRNA silences Drp1 expression, attenuates
oxidative stress and lessens neuronal Injury in the
hippocampal CA1 subfield after TGI
To further clarify the pivotal role of Drp1 in this ische-
mic paradigm of the brain, we also employed molecular
approach by using Drp1-siRNA to knock down its
expression. We first confirmed its efficient delivery by
injecting FITC-conjugated non-targeting siRNA (FITC-
siRNA) into the hippocampal CA1 subfields bilaterally.
Immunofluorescence demonstrated the cytosolic distri-
bution of FITC-siRNA, in both the sham (Fig. 3a) and
TGI (Fig. 3b) groups, in the hippocampal CA1 subfield
24 h after injection. These results indicated the
siRNA could be successfully delivered into neurons
under both sham-operated and ischemia/reperfusion
condition. We then silenced the Drp1 protein expres-
sion by this approach. We found that Drp1-siRNA
decreased p-Drp1(Ser616) protein level in hippocampal
CA1 subfield 24 h after TGI (Fig. 4a). Again as expected,
total Drp1 revealed no significant change between sham
and negative control (NC) siRNA + TGI group but
showed decreased expression in Drp1-siRNA + TGI
group (Fig. 4b). In parallel with the findings from Western
blotting, under a laser-scanning confocal microscope,
more p-Drp1(Ser616)-positive neurons, as revealed by its
colocalization to the NeuN-positive cells, were observed
in the hippocampal CA1 subfield at the same time point
(Fig. 5b) as compared to the sham control animals
(Fig. 5a). Pictures of higher magnification were shown in
5D. Microinjection of Drp1-siRNA into the hippocampus
markedly reduced the numbers of p-Drp1(Ser616)-
positive neurons induced by TGI under the same ex-
perimental conditions (Fig. 5c, f ). Fluorescent double
immunostaining of p-Drp1(Ser616) and COXIV at
higher magnification revealed co-localization of these
two proteins in the mitochondria of hippocampal CA1
neurons at 24 h following TGI (Fig. 5e). Pretreatment with
Drp1-siRNA significantly retarded the extent of protein
Fig. 3 Successful delivery of siRNA into hippocampal CA1 subfield. Fluorescent double staining of FITC-siRNA (green) and DAPI (blue) were observed
in the hippocampal CA1 subfield 24 h after injection of 400 nl FITC-siRNA (10 μM), which was distributed in the cytosol of hippocampal CA1 in both
sham-control (a) and in the rats subjected to TGI-reperfusion for 4 h (b). Scale bar: 10 μm. I/R: ischemia/reperfusion
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oxidation and activated caspase-3 expression in the hippo-
campal CA1 subfield 24 h after TGI (Fig. 6a, b). Both
qualitative (Fig. 6c) and quantitative (Fig. 6d) analyses re-
vealed that downregulation of p-Drp1(Ser616) by siRNA
significantly attenuated TGI-induced DNA fragmentation
in the CA1 subfield of rat hippocampus. These findings
illustrated that inhibition of p-Drp1(Ser616) expression
using Drp1-siRNA may decrease oxidative neuronal dam-
age and DNA fragmentation in the hippocampal CA1 sub-
field after TGI.
Effect of PPARγ agonist on p-Drp1(Ser616) expression,
oxidative stress and neuronal injury in the hippocampal
CA1 subfield after TGI
Although PPARγ agonist including rosiglitazone or pio-
glitazone can reduce inflammation and oxidative damage
as well as diminishes cell death caused by ischemic
injury [23–27], whether PPARγ-dependent pathway can
reduce the expression of p-Drp1(Ser616) and ameliorate
hippocampal injury induced by global ischemia is
currently unknown. To address this issue, pioglitazone
(20 nM) was microinjected into the CA1 subfield
30 min before TGI with or without prior microinjection
of GW9662, a PPARγ antagonist, (500 ng) 30 min before
pioglitazone. Western blotting revealed an increased
p-Drp1(Ser616) protein level in hippocampal CA1
subfield 24 h after TGI, which was reduced by pio-
glitazone pretreatment; moreover, GW9662 reversed
the pioglitazone effect over p-Drp1(Ser616) protein
expression (Fig. 7a). In parallel with the p-Drp1(Ser616)
protein expression, pretreatment with pioglitazone de-
creased TGI-induced protein oxidation and activated
caspase-3 expression, whereas GW9662 partially reversed
this beneficial effect of pioglitazone (Fig. 7b, c). Both quali-
tative (Fig. 7d) and quantitative (Fig. 7e) studies of DNA
fragmentation revealed that pioglitazone in part lessened
TGI-induced DNA fragmentation, which was reversed by
GW9662 pretreatment. Consistently, the extent of hippo-
campal neuronal apoptosis based on TUNEL staining, re-
vealed the same tendency after pioglitazone and GW9662
treatments (Fig. 7f).
Discussion
The results demonstrate that TGI increases p-Drp1(Ser616)
expression, a phosphorylation site important for in-
creasing mitochondrial fission, in the hippocampal
CA1 subfield after TGI. In contrast, no significant
change for total Drp1 expression under TGI. Both the
Drp1 inhibitor Mdivi-1 and the siRNA targeting Drp1
decreased p-Drp1(Ser616) expression, lessened protein
oxidation, and attenuated neuronal damage in the
hippocampal CA1 subfield. These findings suggested
the pivotal role of p-Drp1(Ser616) in TGI-induced
neuronal injury. PPARγ agonist, pioglitazone, reduced
the p-Drp1(Ser616) expression, decreased TGI-induced
oxidative stress, lessened the extents of DNA fragmenta-
tion, and diminished the numbers of TUNEL-positive
neuronal cells; all of these effects were reversed by
GW9662, a PPARγ antagonist. These findings indicated
Fig. 4 Western blotting of p-Drp1(Ser616) and total Drp1 expression
after Drp1-siRNA in the hippocampal CA1 subfield after TGI. After
microinjection with Drp1-siRNA (0.05 nM in a total volume of 400 nl)
into the CA1 subfield 24 h before TGI, total proteins were isolated
from hippocampal CA1 subfield of sham-operated controls, control
siRNA with TGI, or Drp1-siRNA animals after 10 min of TGI with 24 h
reperfusion for detection of p-Drp1(Ser616) in (a) and total Drp1 in (b).
The same blots were also probed with a α-tubulin antibody to serve as
an internal control for equal loading of proteins in each lane. Values
are mean ± SEM from representative blots and quantitative analysis
from 4-6 animals in each experimental group. I/R: ischemia/reperfusion,
NC: negative control siRNA
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Fig. 5 (See legend on next page.)
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that PPARγ-dependent pathway can reduce the expression
of p-Drp1(Ser616) and ameliorate hippocampal injury in-
duced by global ischemia.
Mitochondrial fission that occurs as an early event of
neuronal cell death plays a pivotal role in cerebral ische-
mia [7]. Drp1 is a large GTPase that cycles between the
cytosol and mitochondrial outer membrane to function
as a key contributor in the mitochondrial dynamic
process when the cells encounter various stressful stim-
uli, whereas Drp1-mediated mitochondrial fission and
downstream mitochondrial death pathways are critically
involved in the observed cell death [7, 36]. Phosphoryl-
ation of Drp1 is crucial to regulating mitochondrial dy-
namics [37]. Multiple phosphorylation sites have been
characterized for their functional importance [34]. Drp1
phosphorylation at serine 616 can result in its activation
and recruitment to mitochondria [35]. On the contrary,
fission is inhibited when Drp1 is phosphorylated at
Ser637 [34, 38]. The role of Drp1 in cerebral ischemia is
just beginning to emerge [8, 9, 39]. It has been well dem-
onstrated that knockdown of the fission protein Drp1 or
with Drp1 inhibitors can block toxicity in a glutamate-
induced oxidative stress model in HT22 cells and Drp1
inhibitors-Mdivi a or Mdivi b can reduce infarct volume
in a mouse model of transient focal ischemia [8]. How-
ever, the protective mechanism involving inhibition of
Drp1 or Drp1 phosphorylation is still awaited to clarify
with in vivo cerebral ischemia study. After focal cerebral
ischemia, Drp1 phosphorylation is related to the apop-
totic process in peri-infarct regions [39]. In our recent
study, cerebral ischemia increased p-Drp1(Ser616) ex-
pression with no evident change over total Drp1 and
p-Drp1(Ser637) expression; further, down-regulation of
PINK1 increased p-Drp1(Ser616) expression, heightened
DNA oxidation, and augmented neuronal damage in the
hippocampal CA1 subfield [21]. These studies denoted a
pivotal role of p-Drp1 in cerebral ischemia and attenu-
ation of p-Drp1 (Ser616) levels may exert neuroprotective
effects. In a recent report, preventing dephosphorylation
of Drp1(Ser637) with Mdivi-1 or Drp1-siRNA can pre-
serve mitochondrial networking and ultrastructure follow-
ing heart ischemia/reperfusion model [40].
We have reported before that TGI-induced ROS
generation results in heightened protein oxidation and
neuronal death in the hippocampal CA1 subfield [18, 19].
In this work, concomitantly with heightened protein oxi-
dation, p-Drp1(Ser616) expression was increased (Fig. 2).
It was known that Drp1 mediates mitochondrial fission
[41, 42]. Drp1 activity results from phosphorylation by
cyclin B/cyclin-dependent kinase (CDK), which causes
phosphorylation of Serine 616 and promotes Drp1 recruit-
ment to mitochondria for subsequent fission [41, 42]. The
roles of calcium cascade in the cerebral ischemic paradigm
in terms of necrosis and apoptosis are well established
[43–45]. It was reported that calcium influx across the
plasma membrane was an upstream event governing
mitochondrial fission and ROS generation that can be re-
versed by calcium chelation [46]. Increased intracellular
calcium may cause Drp1 activation in cardiac ischemia
[40]. The identification of mitochondrial calcium unipor-
ter holds important clinical perspective, which allows the
rapid calcium accumulation across the inner mitochon-
drial membrane [47]. It was demonstrated that under
ischemia/reperfusion injury, mitochondria accumulate sig-
nificant amounts of calcium from the cytosol via mito-
chondrial calcium uniporter and blocking mitochondrial
calcium uniporter was demonstrated to exert protective
effects against ischemia/reperfusion injury [48]. In a recent
study, it revealed that mitochondrial calcium uniporter
regulates the process of mitochondrial fission by control-
ling the calcium transport, directly upregulating mito-
chondrial fission proteins Drp1 [49]. All these evidence
denote the importance of calcium and mitochondrial cal-
cium uniporter in mitochondrial dynamics under ischemic
condition.
It was suggested that mitochondrial oxidative stress
modulates Drp1 expression and causes an imbalance be-
tween mitochondrial fission and fusion, resulting in
mitochondrial fragmentation and thus contributing
ultimately to cellular dysfunction [50]. Treatment of an-
tioxidants such as vitamin E or MitoQ can lessen mito-
chondrial fragmentation and Drp1 expression [51, 52].
On the contrary, it was shown that knockdown of Drp1
expression suppressed production of mitochondrial ROS
[53]. Both inhibition of Drp1 expression with antisense
oligonucleotide and a dominant-negative mutant of
Drp1 decrease oxidative stress [54, 55]. In this study,
we showed that Mdivi-1 decreased p-Drp1(Ser616)
(See figure on previous page.)
Fig. 5 Drp1-siRNA downregulates p-Drp1(Ser616) expression in the hippocampal CA1 subfield after TGI. Fluorescent double staining of p-Drp1
(green) and NeuN (red) in the hippocampal CA1 subfield in a sham control group, b ischemia/reperfusion 24 h with negative control siRNA and
c siRNA for Drp1 and ischemia/reperfusion 24 h. NeuN showed the nuclear distribution while p-Drp1 were dispersed in the cytoplasm. Scale bars,
50 μm Merged images with higher magnification demonstrate that p-Drp1(Ser616) and NeuN-positive cells localized separately in the nucleus
and non-nuclear cytoplasm in neurons in (d). Scale bars, 2 μm. A semi-quantitative data about the change of p-Drp1(Ser616) expression after
Drp1-siRNA for Fig. 5 a-c was shown in (f). Fluorescent double staining of p-Drp1(Ser616) (green) and COXIV (blue) in the neuron of the hippocampal
CA1 subfield; merged image shows the co-localization in mitochondria in neurons under the condition of ischemia/reperfusion for 24 h (e). Scale bars,
2 μm. I/R: ischemia/reperfusion, NC: negative control siRNA. COXIV: cytochrome c oxidase subunit 4
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expression, lessened protein oxidation as well as acti-
vated caspases 3, a marker of oxidative stress and
apoptosis respectively (Fig. 2b, c). Mdivi-1 affects total
Drp1 expression as well as phosphorylation level
though the underlying mechanism is not well under-
stood [33, 56]. Mdivi-1 attenuates mitochondrial div-
ision by blocking dynamin GTPase activity, impedes
apoptosis by inhibiting mitochondrial outer membrane
permeabilization and effectively hinders Bid-activated
Bax/Bak-dependent cytochrome c release from mito-
chondria [57].
We then used siRNA strategy to confirm the crucial
role of Drp1 in this ischemic paradigm. Based on im-
munofluorescence studies, we verified the successful de-
livery of siRNA and reducing p-Drp1(Ser616) expression
(Figs. 3, 4 and 5). In supporting the regulatory role of
Fig. 6 Drp1 siRNA attenuates oxidative stress and decreases DNA fragmentation in hippocampal CA1 subfield after TGI. After microinjection with
Drp1 siRNA (0.05 nM in a total volume of 400 nl) into the CA1 subfield 24 h before TGI, Total proteins were isolated from the hippocampal CA1
subfield of sham-operated controls, control siRNA with TGI, or Drp1 siRNA with TGI for protein oxidation in (a) and activated caspase-3 expression
in (b). DNA was isolated from collected hippocampal CA1 subfield of sham-operated controls, vehicle with negative control siRNA, and Drp1-
siRNA 48 h after TGI for detection of DNA fragmentation by PCR assay in (c) Hippocampal CA1 tissues were collected 48 h after TGI for detection
of DNA fragmentation by sandwich ELISA in (d). Values are mean ± SEM from representative blots and quantitative analysis from 5–6 animals in
each experimental group (a and b). Values are fold changes in (d) with reference to sham-control; mean ± SEM of 5–7 animals in each experimental
group. *P < 0.05 vs. sham-control group and #P < 0.05 vs. negative control siRNA+ I/R in the Scheff′e multiple-range test. I/R: ischemia/reperfusion,
NC: negative control siRNA
Chuang et al. Journal of Biomedical Science  (2016) 23:44 Page 10 of 14
Fig. 7 Pioglitazone regulates Drp1 phosphorylation, protein oxidation, DNA fragmentation, and neuronal apoptosis in a PPARγ-dependant pathway
after TGI. The chemical compounds microinjected into bilateral CA1 subfields as following with DMSO, pioglitazone (20 nmol) 30 min before TGI, or
GW9663 (500 ng) 30 min before pioglitazone and 60 min before TGI. Total proteins were isolated from the hippocampal CA1 subfield of
sham-operated controls or treated animals 24 h after 10 min of TGI for detection of p-Drp1 (Ser616) in (a) and protein oxidation in (b)
and activated caspase-3 expression in (c). DNA was isolated from collected hippocampal CA1 subfield of sham-operated controls, DMSO + I/R,
pioglitazone + I/R and GW9662 + pioglitazone 48 h after TGI for detection of DNA fragmentation by PCR assay (d) and hippocampal CA1 tissues
were collected 48 h after TGI for detection of DNA fragmentation by sandwich ELISA in (e). Hippocampal slices were subjected to TUNEL staining to
determine the extents of apoptosis in (f) which showed sham control in (a), ischemia/reperfusion with vehicle control in (b), pioglitazone
with ischemia/reperfusion in (c) and GW9662 + pioglitazone and ischemia/reperfusion in (d). Values are mean ± SEM from representative
blots and quantitative analyses from 5–6 animals in each experimental group (a, b and c); values in (e) are fold changes with reference
to sham-control; mean ± SEM of 5-6 animals in each experimental group. *P < 0.05 vs. sham-control group, #P < 0.05 vs. DMSO + I/R and + P < 0.05
versus Piog + I/R group in the Scheff′e multiple-range test. I/R: ischemia/reperfusion. Piog: pioglitazone
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Drp1 over oxidative stress in ischemic condition, Drp1-
siRNA treatment decreased p-Drp1(Ser616) expression
(Figs. 4 and 5), which was accompanied by attenuated
protein oxidation, lessened apoptotic process and de-
creased neuronal damage (Fig. 6). Based on these results,
Drp1-dependent enhancement of ROS generation is a
more favorable assumption than oxidative stress-
mediated induction of Drp1, at least in our TGI para-
digm. This observation may be vital for therapeutic
purposes for ischemic stroke by impeding the activa-
tion of p-Drp1(Ser616) expression rather than inhib-
ition of oxidative stress only.
In this study, we found that PPARγ agonist- pioglita-
zone decreased p-Drp1(Ser616) expression, lessened oxi-
dative stress as well as apoptotic process, and attenuated
neuronal damage under TGI/reperfusion in the hippo-
campal CA1 subfield, all of which were reversed by
GW9662 (Fig. 7). PPARγ is a ligand-activated transcrip-
tional factor that belongs to the nuclear hormone recep-
tor superfamily and influences the expression of genes
under various physiological or pathological conditions,
including redox balance and vascular integrity [58]. We
and others have shown before that thiazolidinediones
drugs, including rosiglitazone and pioglitazone, possess
characters of PPARγ agonist exerting neuroprotective
effects in various models, which were abrogated by
GW9662, a PPARγ antagonist [31, 59, 60]. Several po-
tential mechanisms related to PPARγ and mitochondrial
dynamic were reported before. Pioglitazone demon-
strates the ability to restoring mitochondrial defects and
mitochondrial networking [61]. Another PPARγ agonist,
ciglitazone, can prevents mitochondrial size reduction in
hippocampal neurons induced by H2O2 [62]. The poten-
tial mechanism may relate to the property of PPARγ be-
ing able to directly induce the expression of several
mitochondria-related proteins including Drp1. PPARγ
agonists have been linked to calcium balance [63, 64],
which may affect Drp1 phosphorylation [65] and offer
the ability of PPARγ to control mitochondrial dynamics
modulation. Another common point for the mitochon-
drial dynamics modulation among these PPARγ agonist
is the capability of activating PPARγ coactivator 1-α
[66, 67], an important molecule that can counteract
excessive oxidative stress and apoptosis in cerebral is-
chemia [68]. Thus, pioglitazone has the potential to
reduce neuronal injury after cerebral ischemia through
mitochondrial dynamic-related proteins and PPARγ-
dependent pathways.
Conclusion
In summary, the present study demonstrated that inhib-
ition of TGI-induced p-Drp1(Ser616) expression by
Drp1 inhibitor and Drp1-siRNA can decrease protein
oxidation, apoptotic process and neuronal damage in the
hippocampal CA1 subfield. PPARγ-dependent pathway
can decrease the expression of p-Drp1(Ser616) and
protect hippocampal CA1 injury induced by global
ischemia.
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